DuPont in agchem R&D deal with Glaxo Wellcome unit

01 February 2000 16:30  [Source: ICIS news]

LONDON (CNI)--US chemicals group DuPont announced on Tuesday a R&D deal to boost its crop protection business using drug discovery technology held by Affymax Technologies, a subsidiary of UK firm Glaxo Wellcome.

DuPont said it would make payments to access and test compounds in Affymax's chemical libraries against its crop protection targets. Development milestone payments and royalties would also be paid to Affymax. Financial details were not disclosed.

Emo Beyer, vice president for strategic R&D planning at DuPont's agriculture and nutrition operations, said the company was keen to identify novel chemical solutions for crop protection.

By: Patrick Reynolds
+44 208 652 3214

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly